← back to search

Xiaobo Li

Guangzhou University of Chinese Medicine · CN
Area of research
Public Health, Environmental and Occupational Health · Genetics
Research interest
Research focused on Toxicity and Decoction, with related work in Artemisinin, Tacrolimus, Mesenchymal stem cell. Notable publications include 'Donor-Derived Mesenchymal Stem Cells Combined With Low-Dose Tacrolimus Prevent Acute Rejection After Renal Transplantation', 'Large-scale Artemisinin–Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa', and 'Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19)'.
h-index
citations
381
works
20
NIH funding
primary concept
email

Recent publications

Chinese Expert Consensus on the Impact of Ambient Air Pollution on Allergic Rhinitis and Recommendations for Mitigation Strategies
Allergy Asthma and Immunology Research 2025cited by 6position: middledoi
Oral acute and subacute toxicity studies as well as safety pharmacology in beagle dogs of total lignans from <i>Arctii Fructus</i>
Drug and Chemical Toxicology 2025cited by 0position: middledoi
Safety assessment of Wuzhuyu decoction extract: acute and subacute oral toxicity studies in rats
Drug and Chemical Toxicology 2024cited by 0position: lastdoi
Acute and subacute oral toxicity assessment of Gancao Xiexin decoction in Sprague-Dawley rats
Frontiers in Pharmacology 2023cited by 10position: lastdoi
Acute and chronic toxicity in Sprague–Dawley rats of orally-administered total lignans from Arctii Fructus, a potential therapeutic drug for diabetes
Regulatory Toxicology and Pharmacology 2023cited by 3position: middledoi
Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19)
BMC Complementary Medicine and Therapies 2022cited by 29position: middledoi
Reproductive and Developmental Toxicity Assessment of Human Umbilical Cord Mesenchymal Stem Cells in Rats
Frontiers in Cell and Developmental Biology 2022cited by 11position: firstdoi
Acute and subacute oral toxicity of artemisinin-hydroxychloroquine sulfate tablets in rats
Regulatory Toxicology and Pharmacology 2022cited by 9position: firstdoi
Reproductive and endocrine effects of artemisinin, piperaquine, and artemisinin-piperaquine combination in rats
BMC Complementary Medicine and Therapies 2022cited by 3position: firstdoi
Acute and subacute oral toxicity of artemisinin-hydroxychloroquine sulfate tablets in beagle dogs
Drug and Chemical Toxicology 2022cited by 0position: firstdoi
Restoring mammary gland structures and functions with autogenous cell therapy
Biomaterials 2021cited by 11position: middledoi
Efficacy and Safety of Qinghao Biejia Decoction in the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Frontiers in Pharmacology 2021cited by 10position: firstdoi
Pharmacokinetics and Toxicokinetics of Artemisinin-Hydroxychloroquine Sulfate Tablets in Rats and Dogs
Evidence-based Complementary and Alternative Medicine 2021cited by 9position: firstdoi
Immunogenicity and toxicokinetics assessment of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys
Life Sciences 2020cited by 4position: firstdoi
Sub-acute toxicological study of artemisinin-piperaquine tablets in rhesus monkeys
Regulatory Toxicology and Pharmacology 2019cited by 9position: firstdoi
Large-scale Artemisinin–Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa
Clinical Infectious Diseases 2018cited by 57position: middledoi
Preclinical evaluation of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys
Toxicology and Applied Pharmacology 2018cited by 9position: middledoi
Ticagrelor with Aspirin on Platelet Reactivity in Minor Stroke or Transient Ischemic Attack: A Randomised, Open-Label, Blinded-Endpoint Trial
SSRN Electronic Journal 2018cited by 0position: middledoi
Determination and Pharmacokinetics of Amygdalin in Rats by LC-MS-MS
Journal of Chromatographic Science 2013cited by 25position: firstdoi
Donor-Derived Mesenchymal Stem Cells Combined With Low-Dose Tacrolimus Prevent Acute Rejection After Renal Transplantation
Transplantation 2012cited by 176position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qin Xu · Guangzhou University of Chinese Medicine11 papers (2018–2024)Yueming Yuan · Guangzhou University of Chinese Medicine10 papers (2019–2024)Jianping Song · Guangzhou University of Chinese Medicine10 papers (2019–2023)Zheng Yuan · Guangzhou University of Chinese Medicine9 papers (2019–2024)Ru Li · Guangzhou University of Chinese Medicine9 papers (2019–2024)Zhiyong Xu · Guangzhou University of Chinese Medicine7 papers (2019–2022)Zhiyong Xu · Guangzhou University of Chinese Medicine4 papers (2020–2025)Qi Wang · Hebei Medical University3 papers (2020–2022)Qi Wang · Heilongjiang University of Chinese Medicine3 papers (2019–2022)Qin Xu · Guangzhou University of Chinese Medicine3 papers (2023–2025)Shouya Zhang · Guangzhou University of Chinese Medicine3 papers (2019–2022)Ruidong Liu · Shandong University3 papers (2020–2022)Jingyun Zhang · Guangzhou University of Chinese Medicine2 papers (2023–2025) · 2 papers (2018–2020)Wanting Wu · Guangzhou University of Chinese Medicine2 papers (2022–2025) · 2 papers (2018–2020)Zhaohui Xu · Guangzhou University of Chinese Medicine2 papers (2023–2025)Jianjia Feng · Guangzhou University of Chinese Medicine2 papers (2022–2022)Kezhi Zhang · Fudan University2 papers (2018–2020) · 2 papers (2018–2020)